Marathon Capital Management recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
4 North Park Drive Hunt Valley, MD 21030-1806
As of the latest 13F report, the guru’s equity portfolio contained 146 stocks valued at a total of $310.00Mil. The top holdings were TROW(33.49%), ENPH(3.03%), and MET(2.13%).
According to GuruFocus data, these were Marathon Capital Management’s top five trades of the quarter.
Fidelity National Financial Inc
The guru sold out of their 121,560-share investment in NYSE:FNF. Previously, the stock had a 1.7% weight in the equity portfolio. Shares traded for an average price of $40.78 during the quarter.
On 08/12/2022, Fidelity National Financial Inc traded for a price of $41 per share and a market cap of $11.33Bil. The stock has returned -12.53% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Fidelity National Financial Inc has a price-earnings ratio of 5.69, a price-book ratio of 1.69, a price-earnings-to-growth (PEG) ratio of 0.27, a EV-to-Ebitda ratio of 3.70 and a price-sales ratio of 0.82.
The price-to-GF Value ratio is 0.79, earning the stock a GF Value rank of 10.
GSK PLC
The guru established a new position worth 81,793 shares in MEX:GSK N, giving the stock a 1.44% weight in the equity portfolio. Shares traded for an average price of MXN1107.52 during the quarter.
On 08/12/2022, GSK PLC traded for a price of MXN701.4 per share and a market cap of MXN71.91Bil. The stock has returned -26.21% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, GSK PLC has a price-earnings ratio of 12.46, a price-book ratio of 3.48, a price-earnings-to-growth (PEG) ratio of 0.87, a EV-to-Ebitda ratio of 7.59 and a price-sales ratio of 1.61.
The price-to-GF Value ratio is 0.75, earning the stock a GF Value rank of 5.
T. Rowe Price Group Inc
During the quarter, Marathon Capital Management bought 38,885 shares of NAS:TROW for a total holding of 912,560. The trade had a 1.43% impact on the equity portfolio. During the quarter, the stock traded for an average price of $127.49.
On 08/12/2022, T. Rowe Price Group Inc traded for a price of $132.26 per share and a market cap of $29.85Bil. The stock has returned -36.54% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, T. Rowe Price Group Inc has a price-earnings ratio of 12.76, a price-book ratio of 3.33, a price-earnings-to-growth (PEG) ratio of 0.82, a EV-to-Ebitda ratio of 7.71 and a price-sales ratio of 4.15.
The price-to-GF Value ratio is 0.78, earning the stock a GF Value rank of 10.
GSK PLC
The guru sold out of their 83,781-share investment in NYSE:GSK. Previously, the stock had a 1.31% weight in the equity portfolio. Shares traded for an average price of $45.4 during the quarter.
On 08/12/2022, GSK PLC traded for a price of $36.03 per share and a market cap of $73.27Bil. The stock has returned -9.21% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, GSK PLC has a price-earnings ratio of 12.56, a price-book ratio of 3.51, a price-earnings-to-growth (PEG) ratio of 0.87, a EV-to-Ebitda ratio of 7.65 and a price-sales ratio of 1.63.
The price-to-GF Value ratio is 0.91, earning the stock a GF Value rank of 5.
Lennar Corp
The guru established a new position worth 49,460 shares in NYSE:LEN.B, giving the stock a 0.94% weight in the equity portfolio. Shares traded for an average price of $64.01 during the quarter.
On 08/12/2022, Lennar Corp traded for a price of $69.58 per share and a market cap of $25.12Bil. The stock has returned -19.51% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Lennar Corp has a price-earnings ratio of 6.06, a price-book ratio of 1.17, a price-earnings-to-growth (PEG) ratio of 0.27, a EV-to-Ebitda ratio of 4.80 and a price-sales ratio of 0.86.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 9.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
